Gregory Steiner, D.D.S., M.S.
Dr. Steiner’s two main interests are travel and a love of the ocean. Dr. Steiner has circumnavigated the globe, taking two weeks off every three months while practicing periodontics to sail from California across the Pacific Ocean, Indian Ocean, Mediterranean Sea, and finally the Atlantic Ocean. Currently, his interests include sailing, surfing, and outrigger canoe paddling.
Dr. Steiner took a sabbatical from dentistry in 1995 to pursue other interests, which led to research identifying the causative agent for the reduction of the cancer incidence rate found in the Pacific Island Nations. Other research led to the development of a medical treatment for alcoholism, which resulted in the issuance of a US patent. As a result of this work, Dr. Steiner was asked to be co-author of the monologue on Cancer in Africa, published by the National Cancer Institute of France.
Eventually turning his interests back to dentistry, Dr. Steiner founded Steiner Laboratories, one of the few companies currently applying tissue engineering principals to the field of bone regeneration. In 2006, Steiner Laboratories received FDA approval for its line of bone grafts. Today, Steiner Laboratories is active in the development of innovative bone grafting materials and surgical therapies to solve some of dentistry’s most challenging problems. At this time, Dr. Steiner splits his time acting as CEO of Steiner Laboratories in Henderson, Nevada, and practicing periodontics and dental implants at Blue Oak Dental Roseville.